This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
PS-3-2 High-Throughput Phenotypic Screening Campaign of 1, 954 FDA-Approved Drugs Reveals 41 Hits With Anti-Myofibroblast Activity in an in Vitro Model of Peyronie's Disease. (1st June 2020)
Record Type:
Journal Article
Title:
PS-3-2 High-Throughput Phenotypic Screening Campaign of 1, 954 FDA-Approved Drugs Reveals 41 Hits With Anti-Myofibroblast Activity in an in Vitro Model of Peyronie's Disease. (1st June 2020)
Main Title:
PS-3-2 High-Throughput Phenotypic Screening Campaign of 1, 954 FDA-Approved Drugs Reveals 41 Hits With Anti-Myofibroblast Activity in an in Vitro Model of Peyronie's Disease